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Objective: there is evidence for superior patency in infra-inguinal bypass procedures in men compared to women. A
large, prospectively planned series was investigated in order to confirm this finding and to determine the origin of this
difference in outcome.
Methods: patients underwent femorodistal bypass surgery and a prospectively planned 12-month follow-up. Outcomes
in male and female patients were compared and investigated for associations with characteristics of the patients and the
surgical procedures.
Results: a total of 517 patients received femorodistal bypass grafts, including 424 vein grafts and 93 prosthetic and vein-
prosthetic composite grafts. Patency was confirmed to be higher in male than in female patients (56% vs. 42%, p=
0.005). Fewer male patients received prosthetic or composite grafts (21% vs. 33%, p=0.005), but the difference in
patency was evident only in patients receiving vein grafts. Female patients were smaller, included fewer smokers (p<0.001)
and had worse symptoms (p=0.03), but none of these characteristics explained the difference in outcome. Patency in
vein grafts was associated with graft diameter (p=0.004), but graft diameter was not significantly associated with sex
(p=0.09) or with body size.
Conclusions: it was confirmed that patency of femorodistal bypasses is significantly higher in males than females. None
of the factors investigated here explain this difference, but the greater use of prosthetic and composite grafts in female
patients suggests that poorer vein quality should be investigated as a possible source of the inferior outcome in female
patients.
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Introduction Material and Methods
Several studies in peripheral artery bypass surgery Patients undergoing femorodistal bypass procedures
have found a superior patency of bypass grafts in were recruited in 21 vascular surgical centres from six
male than in female patients.1–4 Similar findings have countries in northern Europe (Denmark, Ireland, The
been reported in coronary artery bypass surgery.5 Netherlands, Norway, Sweden and the United King-
These differences in patency have not been explained, dom). Data collection was monitored from a co-or-
although it has been postulated that vessel size may dinating centre and validated by reference to original
be an important factor.2 hospital records. The protocol was approved by the
A large, multicentre, prospective, randomised trial appropriate Ethics Committee for each of the par-
of iloprost was performed, which failed to show any ticipating centres.
effect of treatment on outcome.6 The data from this The patients studied were those undergoing bypass
trial were investigated in order to determine if the surgery for severe lower limb ischaemia with the
difference in patency rates between the sexes could be proximal anastomosis above the knee and the distal
confirmed and could be attributed to differences in anastomosis to the tibioperoneal trunk, the anterior
other recorded patient characteristics or the surgical tibial, posterior tibial or peroneal artery. Patients had
procedures performed. to have either trophic lesions or persistent rest pain
requiring analgesia for at least two weeks.
Demographic data, clinical status, ankle and brachial
Doppler pressures were recorded pre-operatively.
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Table 1. Major amputations and mortality in males and females.formula: body mass index in kg/m2=weight in kg/
height in metres2. Body surface area was calculated Outcome Male Female p value
(n=314) (n=203)according to the Dubois formula: body surface area
in cm2=◊(body weight in kg×height in cm×167.2).
Amputations 53 (17%) 52 (26%) 0.03Angiographic run-off was calculated using a method Deaths 55 (18%) 42 (21%) 0.44
which takes into account both the number and state
of the vessels distal to the graft.7 The run-off was
data and with the Rank Sum test for non-parametricscored between 1 and 10, where 1 represents excellent
data. Categorical variables were compared with theoutflow and 10 represents no outflow. Technical details
Mantel–Haenszel Chi-squared test. Life-table patencyof the operation recorded included the graft material,
curves were compared using the log-rank test. As-graft length and diameter. Vein grafts were used when-
sociations of continuous variables with graft patencyever suitable vein was available and the diameter of
were tested using Spearman’s correlation coefficient.the vein graft measured mechanically during surgery.
Postoperative follow-up on all patients was 12
months. Primary patency was defined as patency of
the graft without any further intervention after skin Results
closure in the initial bypass operation. Graft sur-
veillance and subsequent interventions were per- Patency and clinical outcome
formed according to each centre’s own policy.
Three hundred and fourteen males and 203 females
underwent femorodistal bypass surgery. Individual
study centres did not differ significantly in the pro-
Statistical considerations portion of female patients included. The incidence of
major amputations was lower in male patients than
Incidence of major amputations and mortality were in females (p=0.03), but mortality did not differ (Table
calculated using data on all patients entered into the 1). Excluding from the calculation those undergoing
study. The investigation of factors associated with major amputation or dying before bypass occlusion
patency was performed excluding patients who had left 275 males and 180 females. Of these, 55% (CI
died or undergone major amputation with a patent 50–61) of males and 42% (CI 35–49) of females had
bypass in order to avoid any distortion of the analysis primary patency at 12 months (p=0.005). Performing
by factors which might influence likelihood of am- life-table analysis on all patients entered into the study
putation or death, rather than patency. Primary graft confirmed this result (p=0.007) (Fig. 1). Secondary
patency at 12 months was used for all comparisons of patency rates at 12 months were 65% (CI 59–71) in
patency in subgroups of patients. Where appropriate, males and 53% (CI 46–60) in females (p=0.01).
patients receiving vein grafts and those receiving grafts
partly or wholly consisting of prosthetic material were
considered separately.
Univariate analysis was performed on a number of Patient characteristics
variables in order to establish in which preoperative
characteristics males differed from females. Those vari- Male and female patients differed significantly on a
number of pre-operative characteristics (Table 2).ables were identified which were associated with both
sex and patency at 12 months. An association of these Males were significantly older, taller, heavier and had
a larger body surface area than the female patients,variables with patency independently of sex was in-
vestigated and a multiple regression analysis per- but the body mass index (BMI) was similar. A similar
proportion of the male patients were diabetic, but aformed on the variables which appeared to be
potentially important. larger proportion were current smokers at the time of
surgery. Female patients had a worse symptom scoreMean results are given with standard errors and
medians are quoted where data were not normally pre-operatively, but there was no difference in an-
giographic run-off scores.distributed. Graphical displays of 12-month patency
rates are shown with 95% confidence intervals. Dis- Aspirin was used postoperatively by similar per-
centages of the two patient groups, 86 male patientstributions were tested for normality with the Kol-
mogorov–Smirnov test (with Lilliefors’ correction). (27%) and 57 female patients (28%). Use of oral anti-
coagulants in the two groups was also similar, 105Comparisons of continuous variables in two groups
were made with the t-test for normally distributed male patients (33%) and 64 female patients (31%).
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Fig. 1. Primary patency by sex.
Table 2. Preoperative characteristics of male and female patients using all available data for each characteristic.
Characteristic Male Female p value (test∗∗)
n Mean/∗median n Mean/∗median
or no. patients or no. patients
Age (years) 313 71∗ 202 76∗ <0.001 (rs)
Height (cm) 263 175∗ 170 161∗ <0.001 (rs)
Weight (kg) 296 74.4±0.7 194 62.4±0.9 <0.001 (t)
BMI (kg/m2) 258 24.4∗ 168 23.7 0.19 (rs)
Body surface area (cm2) 258 19 034±112 168 16 639±149 <0.001 (t)
Smokers 314 134 (43%) 203 44 (22%) <0.001 (2)
Diabetes mellitus 314 107 (34%) 202 76 (37%) 0.49 (2)
Symptom score 314 3∗ 203 4∗ 0.02 (rs)
Run-off score 260 4.5∗ 175 4.5∗ 0.84 (rs)
∗ indicates that a median is given due to non-parametric distribution.
∗∗ rs=rank sum test, t=t-test, 2=Chi-squared test.
Investigation of patency by sex and diabetic status
indicated that female non-diabetics did markedly
worse compared to female diabetics (p=0.04) and
compared to males, diabetics as well as non-diabetics
(p<0.001) (Fig. 2). Investigation of patency by sex and
smoking status indicated that males did better than
females irrespective of their smoking status (Fig. 3).
Patency results in different graft materials
The frequency of use of the different conduits for a
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(p=0.02) (Table 3). A greater proportion of male
Fig. 2. Primary patency by sex and diabetic status (percentages andpatients than female patients had reversed saphenous
95% CI). (Ε) Male; (Φ) female.vein grafts and female patients were significantly more
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Fig. 4. Primary patency by sex and graft material (percentages andFig. 3. Primary patency by sex and current smoking status (per-
centages and 95% CI). (Ε) Male; (Φ) female. 95% CI). (Ε) Male; (Φ) female.
Table 3. Distribution of different graft materials in all male and Table 5. Association of patency with weight and body surface
female patients included in the study. area (median values).
Material Number of patients (%) Characteristic Patent Occluded p value
(rank sum
Males Females test)
In situ saphenous vein 181 (58%) 111 (55%) Weight (kg) 71.4 68.4 0.03
Reversed saphenous vein 65 (21%) 25 (12%) Body surface area 18 389 17 877 0.03
Vein–vein composite 22 (7%) 20 (10%) (cm2)
Vein–prosthetic composite 13 (4%) 16 (8%)
Prosthetic 32 (10%) 31 (15%)
and 41% in females (p=0.001), whereas in prostheticAll vein 268 (86%) 154 (76%)
Prosthetic or 45 (14%) 49 (24%) and vein–prosthetic composite grafts it was 38% in
vein–prosthetic males and 47% in females (p=0.54) (Fig. 4).
All materials 313 (100%) 203 (100%)
likely than male patients to have either a prosthetic Association of vein diameter, body size and patency
graft or a prosthetic-vein composite graft.
The 12-month primary patency rates with different There was a trend towards a greater diameter of vein
grafts in males, median 4.0 mm, compared to females,graft materials are shown for male and female patients
(Table 4). Primary patency was significantly higher in median 3.3 mm (p=0.09). Vein graft diameter was also
found to be greater in patients with a patent bypassmale than in female patients overall (p=0.009). The
higher patency in males can be seen to originate prim- at 12 months, median 4.0 mm, than in patients who
had suffered an occlusion, median 3.5 mm (p=0.004).arily from the patients receiving in situ vein grafts.
Primary patency in all vein grafts was 59% in males Weight and body surface area were found to be
Table 4. Primary patency rate at 12 months by sex and graft material in all patients surviving to 12 months or bypass occlusion.
Material Number of patients with primary patency (%)
Males Females p value
(2 test)
In situ saphenous vein 89/156 (57%) 36/96 (38%)
Reversed saphenous vein 36/54 (67%) 12/24 (50%)
Vein–vein composite 10/20 (50%) 8/17 (47%)
Vein–prosthetic composite 5/13 (38%) 7/14 (50%)
Prosthetic 12/32 (38%) 13/29 (45%)
All vein grafts 135/230 (59%) 56/137 (41%) 0.001
All prosthetic grafts 17/45 (38%) 20/43 (47%) 0.54
All materials 152/275 (55%) 76/180 (42%) 0.009
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associated with patency in the study group as a whole due to the methods used: the multicentre design with
(Table 5). However, the parameters of body size were different techniques for assessing minimum vein dia-
not found to be associated with bypass patency in- meter and the mixture of in situ, reversed and composite
dependently of sex. In addition, the association of vein vein grafts might have reduced the reliability and sensi-
diameter with patency could not be attributed to an tivity of the findings. However, Wengerter also failed
association with body size as none of the various to find any association of vein diameter with sex in a
indicators of body size, height, weight, body mass smaller, but more homogeneous patient group.12
index and body surface area, showed an association It was postulated that the relationship of vein graft
with vein diameter. diameter to patency might explain the patency dif-
Multiple regression analysis confirmed that of the ference with sex by virtue of a correlation of vessel
factors investigated here, only sex and graft diameter diameter with body size. Of the various parameters
were independently associated with patency at 12 of body size investigated, weight and body surface
months. area were correlated with both sex and patency. How-
ever, the associations of weight and body surface area
with graft patency are apparently not the explanation
for the association of sex with patency, but rather the
Discussion converse, as there was no association of either weight
or body surface area with patency in male or female
This study found a significant difference between prim- patients alone. In addition, there were no significant
ary bypass patency in males and females undergoing correlations of any of the parameters of body size with
femorodistal bypass surgery. The patency differences vein graft diameter.
were also reflected in the amputation rates, but not in The average age of the patients at the time of surgery
mortality. Similar differences in patency have been re- in this study probably reflects the later onset of ath-
ported in peripheral bypasses previously,1–4 although erosclerotic disease in women. Although increased age
another series found similar results in males and fe- at the time of surgery has been associated with poorer
males.8 Studies of patients undergoing coronary artery outcome after peripheral bypass surgery when mor-bypass grafting (CABG) have reported similar sex-re-
tality is included,13 there does not appear to be anlated differences,9,10 although one study found the in-
association with bypass failure alone, suggesting thatcidence of repeat revascularisation greater in women
this is not a factor in the poorer patency in women.after CABG, but lower in women after percutaneous
Other factors which are associated with a poorcoronary angioplasty.11 It has been postulated that sex-
clinical outcome, diabetes, smoking and clinical symp-related differences in the outcome of CABG might be a
toms, were investigated. Diabetes has been suggestedresult of smaller blood vessels in females.2 The as-
to be a factor in the poorer patency in women.4 How-sociation of vessel size with sex in coronary bypass has
ever, in the study population as a whole and in-been documented,9 but no data has been reported on
dependently of sex there was no association of diabetesthe association of vessel size with sex to explain the
with bypass failure, a finding also reported pre-outcome of peripheral reconstructions.
viously.14 Diabetes has also previously been re-In this study the difference between results in males
ported to be associated with a greater likelihood ofand females arose primarily in those with in situ
patency,15 a finding reproduced in the female popu-procedures, and was not evident at all in patients with
lation in this study. Smoking was more than twice asprosthetic grafts. This suggests that the origin of the
common amongst male patients and there was nodifference may lie in some quality of the vein used as
overall association of smoking with bypass failure ina conduit. Since vein grafts, and in situ procedures
the study population, in contrast to previous research.15in particular, comprised the majority of the study
Preoperative symptom severity, which was greater inpopulation, this afforded the opportunity to in-
women, has previously been reported, as in this study,vestigate the possibility that the graft diameter is
not to be associated with the patency rate of distalimportant in the aetiology of the sex difference in
bypasses,15 although contrary evidence has also beenpatency.
presented indicating that presence of tissue necrosisVein graft diameter was strongly associated with pat-
is a risk factor.16 The use of antithrombotic drugs toency in this study, but only showed a weak association
prevent graft occlusion was surprisingly infrequent,with sex. A smaller, single-centre study has also re-
but similar in males and females.ported an association of vein diameter with the patency
A possible explanation for the difference in patencyof reversed vein grafts.12 The weak association of vein
diameter with sex in the present study may have been is a poorer quality of vein conduit available in women,
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